The Legal Board of Appeal (the "Board") of the European Patent Office (EPO) recently suggested that the owner of an artificial intelligence (AI) machine could possibly be listed as an inventor of an AI-generated Invention.

PatentNext Summary: As a general rule, software-related patents should include an algorithm. An algorithm provides support for a software-related patent in a variety of ways...

In the pharmaceutical industry, where innovation cycles span decades and billions of dollars hinge on patent protection...

Growing up in a family deeply rooted in medicine, I had a unique perspective on the field. My grandparents attended Meharry Medical College...

Artificial intelligence is reshaping health care by powering medical devices and diagnostic tools that are increasingly precise, adaptive, and data driven.

Today’s drug development programs routinely span continents: distributed research teams, multinational clinical trial networks, and complex webs of cross-border licensing, contract manufacturing...

Recent Federal Circuit decisions call into question the value of patents broadly claiming inventions on antibodies and their function in treating debilitating diseases.

n Oil States Energy Services., LLC v. Greene's Energy Group, LLC, Justice Thomas, writing for a 7-2 majority of the Supreme Court, explained that inter partes review proceedings do not violate Article III...

Artificial Intelligence (AI) is revolutionizing various sectors, and the medical device industry is no exception.

Seven judges of the fractured court decided that the Patent Trial and Appeal Board (PTAB) may not—as it has long been doing— place on a patent owner the burden of proving patentability of a claim it moves to amend during an AIA trial.

On February 9, 2023 the PTAB issued a Final Written Decision in Early Warning Services, LLC and Samsung Electronics Co., Ltd. v. WePay Global Payments LLC, determining...

AI chatbots have grown increasingly ubiquitous over the last year. For example, the basic version of ChatGPT is a conversational chatbot capable of understanding natural language...

Increasingly, artificial intelligence (AI) tools like ChatGPT and GitHub Copilot are reshaping corporate operations. They can boost efficiency, particularly in software development and content creation.

The success of a life sciences company relies on its research and development (R&D) and maintaining a robust pipeline of clinical products. Essential factors in building...

In Wi-Fi One, LLC v. Broadcom Corporation, an en banc panel of the Federal Circuit decided on January 8, 2018, that the PTAB's application of the 35 U.S.C § 315(b) ...

The Supreme Court held that PTAB decisions instituting IPR are final and non-appealable and that the language of 35 U.S.C. § 314(d) "indicates that a party generally cannot contend on appeal that the agency should have refused "to institute an inter partes review."

In Indivior UK Ltd. v. Dr. Reddy's Laboratories S.A., Appeals 2020-2073, -2142 (Fed. Cir. Nov. 24, 2021), the Federal Circuit affirmed a Patent Trial and Appeal Board's final decision canceling claims...

We have previously explored the teachings by the late U.S. District judge Milton I. Shadur about answering a complaint and pleading affirmative defenses.

In Hunting Titan Inc. v. DynaEnergetics GmbH & Co. KG, Case IPR 2018-00600 (PTAB Jul. 6, 2020), the Patent Trial and Appeal Board's Precedential Opinion Panel (POP)

As nuclear energy expands globally to meet climate goals, the unresolved challenge of nuclear waste disposal demands urgent attention. Marshall Gerstein attorney Christopher Zahn examines why international cooperation and coordinated regulatory frameworks will be essential to developing sustainable long-term waste solutions that can support the industry's growth.